ask="8.90"
ask_size="500"
average_daily_volume="57137"
bid="5.50"
bid_size="500"
book_value="-19.19"
change="-0.19"
change_from_200_day_moving_average="-0.21"
change_from_50_day_moving_average="0.03"
change_from_52_week_high="-27.56"
change_From_52_week_low="1.07"
change_in_percent="-2.59%"
close="7.16"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-8.04"
ebitda="-18.31M"
eps_estimate_current_year="-1.07"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-1.41"
ex_dividend_date="N/A"
float_shares="832000"
high="7.57"
high_52_weeks="34.72"
last_trade_date="1/26/2017"
last_trade_price="7.16"
last_trade_size="100"
last_trade_time="3:57pm"
low="6.99"
low_52_weeks="6.09"
market_capitalization="17.45M"
moving_average_200_day="7.37"
moving_average_50_day="7.13"
name="KalVista Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="10.64"
open="7.40"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-2.91%"
percent_change_from_50_day_moving_average="+0.35%"
percent_change_from_52_week_high="-79.38%"
percent_change_from_52_week_low="+17.57%"
previous_close="7.35"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="10.11"
revenue="1.77M"
shares_outstanding="2437000"
short_ratio="1.55"
stock_exchange="NGM"
symbol="KALV"
volume="66619"
weeks_range_52="6.09 - 34.72"
